Contacts, documents and full notice history are available with a subscription.
Combined Synopsis/Solicitation NONE Expired 1 notice 2 documents

Provision of Bordetella-Free Baboons for Pertussis Infection and Vaccination Studies 75F40126Q00204

Solicitation 75F40126Q00204 Copied Notice ID a3a0d837a54747d39a3893ac8c767908 Copied HEALTH AND HUMAN SERVICES, DEPARTMENT OF — FOOD AND DRUG ADMINISTRATION
SAM.gov
Posted
Jun 29, 2026
Deadline
Jul 10, 2026
Set-aside
NONE
NAICS
112990
PSC
8820

Summary

AI-generated · Jun 30, 2026

Acquire and deliver twenty Bordetella-free baboons to support pertussis infection and vaccination studies using the baboon model developed at FDA CBER. Pertussis is an acute, highly contagious respiratory disease caused by Bordetella pertussis, and a deeper understanding of why current vaccines fail to control the disease remains a critical public health need.

The research aims to refine the baboon model by establishing infection through natural transmission, enabling a more precise evaluation of differences between licensed acellular pertussis vaccines that fail to prevent infection and whole-cell vaccines that reduce infection.

6/29/2026; See attached amendment 1 to the combined synopsis/solicitation. Pertussis is an acute, highly contagious, potentially life-threatening respiratory disease, caused by the Gram-negative bacterium Bordetella pertussis. The underlying factors leading to the failure of public health measures to control pertussis disease using currently licensed vaccines are poorly understood. A more complete understanding of this disease and of the mechanisms of vaccine-mediated protection is a critical public health need. The baboon model of pertussis, developed in the laboratories of the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), is the only animal model of pertussis that recapitulates the disease as observed in human patients. Refinement of the baboon model to include establishment of infection by means of natural transmission will enable a more refine evaluation of the differences between the licensed acellular pertussis vaccines that fail to prevent infection and the whole cell vaccines that reduce infection. The performance of this study requires the purchase and delivery of twenty, Bordetella-free baboons.

From Combined Synopsis/Solicitation posted on Jun 29, 2026

Notice history

1
  1. Combined Synopsis/Solicitation LATEST Posted Jun 29, 2026 View

Details

Solicitation number 75F40126Q00204
Notice ID a3a0d837a54747d39a3893ac8c767908
Notice type Combined Synopsis/Solicitation
Product / Service (PSC) 8820
NAICS 112990
Set-aside No Set aside used
Place of performance Silver Spring, Maryland
Archive date Jul 25, 2026

Award Information

Not yet awarded

Contacts

primary
David Kramer

Email

secondary
Nick Sartain

Email

Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF
FOOD AND DRUG ADMINISTRATION
FOOD AND DRUG ADMINISTRATION

Place of Performance

Silver Spring, Maryland 20993
USA

Dates

Posted Jun 29, 2026 1 month ago
Last Updated Aug 06, 2026 1 day ago
Due Jul 10, 2026 4 weeks ago